New Insights into Automatic Treatment Planning for Cancer Radiotherapy Using Explainable Artificial Intelligence.

ArXiv Pub Date : 2025-08-19
Md Mainul Abrar, Xun Jia, Yujie Chi
{"title":"New Insights into Automatic Treatment Planning for Cancer Radiotherapy Using Explainable Artificial Intelligence.","authors":"Md Mainul Abrar, Xun Jia, Yujie Chi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to uncover the opaque decision-making process of an artificial intelligence (AI) agent for automatic treatment planning.</p><p><strong>Approach: </strong>We examined a previously developed AI agent based on the Actor-Critic with Experience Replay (ACER) network, which automatically tunes treatment planning parameters (TPPs) for inverse planning in prostate cancer intensity modulated radiotherapy. We selected multiple checkpoint ACER agents from different stages of training and applied an explainable AI (EXAI) method to analyze the attribution from dose-volume histogram (DVH) inputs to TPP-tuning decisions. We then assessed each agent's planning efficacy and efficiency, and evaluated their policy space and final TPP tuning space. Combining findings from these approaches, we systematically examined how ACER agents generated high-quality treatment plans in response to different DVH inputs.</p><p><strong>Main results: </strong>Attribution analysis revealed that ACER agents progressively learned to identify dose-violation regions from DVH inputs and promote appropriate TPP-tuning actions to mitigate them. Organ-wise similarities between DVH attributions and dose-violation reductions ranged from 0.25 to 0.5 across tested agents. While all agents achieved comparably high final planning scores, their planning efficiency and stability differed. Agents with stronger attribution-violation similarity required fewer tuning steps ( 12-13 vs. 22), exhibited a more concentrated TPP-tuning space with lower entropy ( 0.3 vs. 0.6), converged on adjusting only a few key TPPs, and showed smaller discrepancies between practical tuning steps and the theoretical steps needed to move from initial values to the final TPP space. Putting together, these findings indicate that high-performing ACER agents can effectively identify dose violations from DVH inputs and employ a global tuning strategy to achieve high-quality treatment planning.</p><p><strong>Significance: </strong>This study demonstrates that the AI agent learns effective TPP-tuning strategies, exhibiting behaviors similar to those of experienced human planners. Improved interpretability of the agent's decision-making process may enhance clinician trust and inspire new strategies for automatic treatment planning.</p>","PeriodicalId":93888,"journal":{"name":"ArXiv","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393249/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ArXiv","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aims to uncover the opaque decision-making process of an artificial intelligence (AI) agent for automatic treatment planning.

Approach: We examined a previously developed AI agent based on the Actor-Critic with Experience Replay (ACER) network, which automatically tunes treatment planning parameters (TPPs) for inverse planning in prostate cancer intensity modulated radiotherapy. We selected multiple checkpoint ACER agents from different stages of training and applied an explainable AI (EXAI) method to analyze the attribution from dose-volume histogram (DVH) inputs to TPP-tuning decisions. We then assessed each agent's planning efficacy and efficiency, and evaluated their policy space and final TPP tuning space. Combining findings from these approaches, we systematically examined how ACER agents generated high-quality treatment plans in response to different DVH inputs.

Main results: Attribution analysis revealed that ACER agents progressively learned to identify dose-violation regions from DVH inputs and promote appropriate TPP-tuning actions to mitigate them. Organ-wise similarities between DVH attributions and dose-violation reductions ranged from 0.25 to 0.5 across tested agents. While all agents achieved comparably high final planning scores, their planning efficiency and stability differed. Agents with stronger attribution-violation similarity required fewer tuning steps ( 12-13 vs. 22), exhibited a more concentrated TPP-tuning space with lower entropy ( 0.3 vs. 0.6), converged on adjusting only a few key TPPs, and showed smaller discrepancies between practical tuning steps and the theoretical steps needed to move from initial values to the final TPP space. Putting together, these findings indicate that high-performing ACER agents can effectively identify dose violations from DVH inputs and employ a global tuning strategy to achieve high-quality treatment planning.

Significance: This study demonstrates that the AI agent learns effective TPP-tuning strategies, exhibiting behaviors similar to those of experienced human planners. Improved interpretability of the agent's decision-making process may enhance clinician trust and inspire new strategies for automatic treatment planning.

利用可解释的人工智能对癌症放疗自动治疗计划的新见解。
目的:本研究旨在揭示人工智能(AI)代理在自动治疗计划中的不透明决策过程。方法:我们研究了先前开发的基于Actor-Critic with Experience Replay (ACER)网络的AI代理,该代理可以自动调整治疗计划参数(TPPs),以便在前列腺癌调强放疗中进行反向计划。我们从不同的训练阶段选择了多个检查点ACER代理,并应用可解释AI (EXAI)方法来分析剂量-体积直方图(DVH)输入对tpp调优决策的归因。然后,我们评估了每个代理的规划效能和效率,并评估了他们的政策和最终的TPP调整空间。结合这些分析,我们系统地研究了ACER药物如何根据不同的DVH输入产生高质量的治疗计划。结果:归因分析显示,ACER药物逐渐学会从DVH输入中识别剂量违反区域,并促进适当的tpp调节行动来减轻它们。在测试的试剂中,DVH归因和剂量违反减少之间的器官相似性从0.25到0.5不等。归因违反相似度越高的智能体需要的调整步骤越少(~12-13 vs. 22), tpp调整空间越集中,熵值越低(~0.3 vs. 0.6),只会收敛于调整几个tpp,实际和理论的调整步骤差异越小。综上所述,这些发现表明,高性能宏碁药物可以有效地识别DVH输入的剂量违规,并采用全局调整策略来实现高质量的治疗计划,就像熟练的人类计划者一样。意义:更好地解释代理人的决策过程可能会增强临床医生的信任,并激发自动治疗计划的新策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信